News

Reportedly, the DEA has officially lifted the restrictions against the use of electronic prescribing for controlled substances (schedule II – schedule V), which have been the single greatest

Under the contract with ProBioGen, AFFiRiS is expected to evaluate HuALN technology as a human organoid model to investigate drug-related effects in the context of the human immune

The agreement grants Taconic a worldwide, non-exclusive license to use various patented AvGFP variants in the generation and commercialisation of genetically modified rodent models. AvGFP technology also can

Akela Pharma has posted a net income of $14.06m, or $0.46 per diluted share, compared $13.6m, or $0.63 per diluted share, for the prior year period. For the

In the trial, NCX 434 has improved oxygen saturation in the eye. The effects of intravitreal injections of NCX 434 or triamcinolone, a reference steroid, on oxygen saturation

Axanum is a fixed-dose combination containing low-dose ASA (acetylsalicylic acid) and the active ingredient of the PPI Nexium developed by AstraZeneca for the prevention of cardio- and cerebrovascular

Reportedly, the new office is located at Av. das Americas, 500, Downtown Bloco 11, Loja 108, 26640-100 Rio de Janeiro (RJ), Brazil. The new BTS office is headed

According to Mucosis, the loan will be redeemed only if the FluGEM clinical development program is concluded successfully. Mucosis develops vaccines on the basis of its Mimopath technology,

The licenses granted to OMJ include worldwide licenses to Orexo’s ongoing OX-CLI and OX-ESI programs focusing on discovering and developing new small-molecule treatments for asthma, chronic obstructive pulmonary